PDFWAC 296-823-180

Additional requirements for HIV and HBV research laboratories and production facilities.

Summary
Your responsibility:
To implement and enforce these additional rules in research laboratories and production facilities engaged in the culture, production, concentration, experimentation, and manipulation of HIV and HBV.
EXEMPTION:
This section does not apply to clinical or diagnostic laboratories engaged solely in the analysis of blood, tissues, or organs.
Note:
Production and research facilities: Hepatitis C (HCV) is the virus involved in most cases of parenterally transmitted (bloodborne) non-A, non-B hepatitis in the United States. Most individuals who contract HCV become chronically infected (85%) and develop chronic hepatitis (70%). It is recommended that you also follow these requirements for HCV production and research facilities.
You must meet the requirements …
in this section:
Prepare, review, and update a biosafety manual
Follow these special practices for the work area
Make sure these practices for contaminated material and waste are followed
Make sure these special practices for personal protective equipment (PPE) and other safeguards are followed
Protect vacuum lines
Use and handle hypodermic needles and syringes appropriately and safely
Handle all spills and accidents properly
Post signs
Provide additional training for facility employees
Furnish a sink for washing hands and a readily available eye wash facility
Make sure these additional criteria are followed for HIV and HBV production facilities
[Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050. WSR 15-23-086, § 296-823-180, filed 11/17/15, effective 12/18/15. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. WSR 04-12-070, § 296-823-180, filed 6/1/04, effective 9/1/04; WSR 03-09-110, § 296-823-180, filed 4/22/03, effective 8/1/03.]